| Sandoz Pharmaceuticals AG - Dabigatran Sandoz 110 mg, Hartkapseln | | 68658 | | 01 | | Dabigatran Sandoz 110 mg | | Hartkapseln | | B01AE07 | | Dabigatran Etexilate | | 07.06.2023 | | |
| | Composition | | dabigatranum etexilatum 110 mg ut dabigatrani etexilati mesilas, acidum tartaricum, hypromellosum, talcum, hydroxypropylcellulosum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: hypromellosum, E 171, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.7 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| Dabigatranum Etexilatum | 110 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Dabigatranum Etexilatum | 110 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Nigrum) | | | | Acide Tartarique | | | | Carmellosum Natricum Conexum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Propylenglycol | | | | Talcum | | |
| |
| |
|
